Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease-Reference-Cited by-同舟云学术

Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease

Published:2012-04-02 Issue:4 Volume:7 Page:e34138
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Thornton Emma,Vink Robert

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Epidemiology of Parkinson's disease.;G Alves;J Neurol,2008

2. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.;L-W Chen;Current Drug Targets,2004

3. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.;AM Depino;Eur J Neurosci,2003

4. Glial reactions in Parkinson's disease.;PL McGeer;Mov Disord,2008

5. Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.;RL Mosley;Clin Neurosci Res,2006

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Gastrointestinal Symptoms in Parkinson’s Disease;Journal of Clinical Gastroenterology;2024-01-04

2. Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer’s Disease;Molecular Neurobiology;2023-12-13

3. Novel trajectories of the NK1R antagonist aprepitant in rotenone-induced Parkinsonism-like symptoms in rats: Involvement of ERK5/KLF4/p62/Nrf2 signaling axis;Chemico-Biological Interactions;2023-08

4. N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal;Bioorganic Chemistry;2022-09

5. Fiscalin Derivatives as Potential Neuroprotective Agents;Pharmaceutics;2022-07-12